<DOC>
	<DOC>NCT01465282</DOC>
	<brief_summary>The purpose of this study is to evaluate the effectiveness of 3 dose strengths of CT327 ointment (0.05%, 0.1% and 0.05% w/w) compared to a placebo, when applied twice daily for up to 8 weeks, to the psoriatic plaques of patients with psoriasis vulgaris.</brief_summary>
	<brief_title>Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Male and female subjects aged at least 18 years. Stable psoriasis vulgaris Subjects with guttate, erythrodermic, exfoliative or pustular psoriasis.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>psoriasis vulgaris</keyword>
	<keyword>topical ointment</keyword>
</DOC>